Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? by V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva

“…According to the Russian epidemiological study EPOHA-CHF, more than half of patients with CHF have preserved left ventricular ejection fraction (LV EF). …”
Get full text

THE ROLE OF FACTORS AFFECTING THE FORMATION OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION by M. V. Kurkina, A. G. Avtandilov, I. A. Krutovcev

Get full text

FEATURES OF CEREBRAL HEMODYNAMICS AND MANIFESTATIONS OF HEPATIC ENCEPHALOPATHY IN CIRRHOSIS OF VIRAL ETIOLOGY AT DIFFERENT COMPENSATION STAGES WITH PRESERVED LEFT VENTRICULAR EJECTION FRACTION by V. E. Kulikov, T. A. Emelina, O. G. Kazakova, K. V. Nikolaevа, M. E. Hapman, M. A. Tonеeva

“…To study the features of the parameters of cerebral hemodynamics in extra and intracranial regions in viral hepatic cirrhosis A, B, C classes according to Child-Pugh with different serum levels of interleukin-2, interleukin-6 and tumor necrosis factor alpha and preserved left ventricular ejection fraction for improvement of diagnostics of stages of chronic hepatic encephalopathy.Material and methods. 107 patients with viral cirrhosis A, B, C classes according to Child-Pugh with different serum levels of interleukin-2, interleukin-6 and tumor necrosis factor alpha were included into the study. …”
Get full text

Correction of anemia using an iron supplement with a hepcidin-independent absorption mechanism in patients with chronic heart failure with preserved left ventricular ejection fraction by A. A. Gurkina, N. I. Stuklov, V. A. Kokorin, R. R. Gimadiev, N. V. Varekha

Subjects: Get full text

ATRIAL FIBRILLATION AND ARTERIAL HYPERTENSION: GENDER DIFFERENCES OF VENTRICULOATRIAL REMODELING WITH PRESERVED EJECTION FRACTION by Zh. D. Kobalava, E. V. Kokhan, G. K. Kiyakbaev, A. A. Shavarov

Get full text

Echocardiographic assessment of left atrial structural and functional changes after catheter ablation in paroxysmal atrial fibrillation with preserved ejection fraction by Qi Zhang, Nan Nan Liu, Jing Shu Sun, Zu Lu Wang, Ming Liang, Gui Shen Li, Mei Yi Wang

“…At 1 day post-ablation, left ventricular ejection fraction (LVEF), peak early LA diastolic strain (LASRe), peak late LA diastolic strain (LASRa), and their strain rates were lower than baseline, while LA ejection fraction (LAEF) was higher (all P < 0.05). …”
Get full text

Heart Failure with Preserved Ejection Fraction in the Indian Context by Rajeev Gupta, Mahesh Choudhary, Soneil Guptha

“…Heart failure with preserved ejection fraction (HFpEF) is defined as a clinical syndrome with current or prior symptoms or signs caused by a structural or functional abnormality with left ventricular EF ≥50%, corroborated by either elevated natriuretic peptides or objective evidence of cardiogenic pulmonary or systemic congestion diagnosed with imaging or hemodynamic measurements. …”
Get full text

Imaging in Heart Failure with Preserved Ejection Fraction: A Multimodality Imaging Point of View by Serkan Ünlü, Özge Özden, Ahmet Çelik

“…Heart failure with preserved ejection fraction (HFpEF) is an important global health problem. …”
Get full text

NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS by O. M. Drapkina, L. O. Palatkina

“…Increasing number of patients with symptoms of CHF but without systolic dysfunction has drawn the attention of specialists to so-called CHF with preserved ejection fraction. Prognosis in CHF with preserved ejection fraction may be as bad as in CHF with reduced ejection fraction. …”
Get full text

Sodium–Glucose Cotransporter 2 Inhibitors in Heart Failure with Preserved Ejection Fraction: Rationale for and Practical Use of a Successful Therapy by Mauro Gori, Emilia D’Elia, Edoardo Sciatti, Michele Senni

“…Heart failure (HF) with preserved left ventricular ejection fraction is a common disease with a poor prognosis and rising prevalence in the community. …”
Get full text

The oxytocin-oxytocin receptors system — a new pathogenetic mechanism in the development of diabetic phenotype of heart failure with preserved ejection fraction in women by A. D. Starchenko, Yu. V. Liskova, A. A. Stadnikov

“…To determine the pathogenetic role of the oxytocinergic system in the development of myocardium structural and functional changes in women with heart failure with preserved ejection fraction (HFpEF) associated with type 2 diabetes mellitus (DM2T) (diabetic phenotype of HFpEF).Material and methods. …”
Get full text

Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors by Erez Marcusohn, Ofer Kobo, Maria Postnikov, Danny Epstein, Yoram Agmon, Lior Gepstein, Yaron Hellman, Robert Zukermann

“…Methods: This retrospective study was conducted in a large tertiary care centre and compared patients who experienced deterioration of LV ejection fraction (EF) during paroxysmal AF, demonstrated by precardioversion transoesophageal echocardiography with patients with preserved LV function during AF. …”
Get full text

DIABETIC CARDIOMYOPATHY. RESISTIN: A CONTROL OF A MYOCARDIAL HYPERTROPHY by An. A. Aleksandrov, O. A. Shatskaya, S. S. Kuharenko, M. N. Yadrihinskaya, E. N. Abdalkina, E. N. Drozdova, M. V. Shestakova

“…To evaluate the association of serum resistin with morphological and functional indices of hypertrophic myocardium in patients with type 2 diabetes and chronic heart failure (CHF) with preserved left ventricular ejection fraction.Material and methods. …”
Get full text

Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure by V. I. Podzolkov, N. A. Dragomiretskaya, I. G. Beliaev, Ju. S. Kucherova, A. V. Kazadaeva

“…Patients with CHF included patients with preserved left ventricular ejection fraction (HFpEF; n=27, intermediate ejection fraction (HFmrEF; n=25) and reduced ejection fraction (HFrEF; n=28). …”
Get full text

Clinical features of heart failure in patients with atrial fibrillation: the role of the endovascular left atrial appendage closure by D. V. Pevzner, N. S. Kostritca, I. A. Merkulova, O. B. Dorogun, A. L. Komarov, I. S. Yavelov

“…Most patients in the study had class I-III HF with preserved left ventricular ejection fraction (93,5%). …”
Get full text

Chronic Heart Failure in Rheumatoid Arthritis Patients (Part II): Difficulties of Diagnosis by D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova

“…HF in patients with RA is characterized by a predominance of HF with a preserved left ventricular ejection fraction (LVEF). …”
Get full text

STRUCTURAL AND FUNCTIONAL HEART PARAMETERS IN PATIENTS WITH CHRONIC HEART FAILURE DEPENDING ON DIFFERENT BLOOD MIDDLE MASS MOLECULES LEVELS by M. A. Kondratyuk, O. M. Radchenko

“…The patients with the highest MMM levels were specified by low left ventricular ejection fraction (p&lt;0.05), the largest size of right ventricle, the lowest rate of preserved left ventricular function and high rate of diagnosis of increased sizes of the left atrium, interventricular septum and right ventricle.Conclusion. …”
Get full text

Galectin-3 as a Marker of Cardiorenal Syndrome in Patients with Chronic Heart Failure by V. I. Podzolkov, N. A. Dragomiretskaya, A. V. Kazadaeva, Yu. G. Belyaev, A. V. Tolmacheva

“…To assess the effect of renal dysfunction on the galectin-3 level in patients with chronic heart failure (HF) with preserved, intermediate and reduced left ventricular ejection fraction (EF).Material and methods. …”
Get full text

Cardiomyopathy with Restrictive-Hypertrophic Phenotype and Initial Morphological Diagnosis “Amyloidosis” as a Manifestation of Danon Disease in a Woman by O. V. Blagova, E. A. Kogan, V. P. Sedov, Yu. A. Lutokhina, A. V. Nedostup, A. V. Ott, L. M. Dashinemaeva, E. V. Zaklyazminskaya

“…The examination revealed: a moderate degree of left ventricular hypertrophy (up to 17 mm), its diffuse nature and simultaneous involvement of the right ventricle, signs of heart failure due to severe restrictive disorders with preserved ejection fraction. …”
Get full text

T1 and T2 Mapping in Uremic Cardiomyopathy: An Update by Luca Arcari, Giovanni Camastra, Federica Ciolina, Massimiliano Danti, Luca Cacciotti

“…It is characterised by a left ventricular (LV) hypertrophy phenotype, diastolic dysfunction and generally preserved LV ejection fraction. …”
Get full text